Physician

Sonya Joy Inderbitzin-Fischer, MD

According to 2025 Medicare claims, Sonya Inderbitzin-Fischer, MD (NPI: 1184128670) practices hematology in the Grand Rapids-Wyoming-Kentwood, MI market, with the plurality of this provider's patient population coming from Kent, MI. This provider's primary affiliated billing organization is CANCER & HEMATOLOGY CENTERS OF WESTERN MI, P.C. (NPI: 1528018389; TIN: 382777354) and primary practice location at 49424-8217.

Inderbitzin-Fischer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 80 traditional Medicare patients, billed 10,478 HCPCS/CPT codes, and received $177,512 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 273 prescription claims across 59 beneficiaries totaling $504,085 in drug costs, led by Venclexta (Venetoclax). Open Payments data shows 7 records totaling $364. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $605 to $504,085. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$89K$178K2024 Medicare payment: $177,512 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
20248010,478$177,512

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$252K$504K2018 Drug cost: $605 (USD; Tot_Drug_Cst)2019 Drug cost: $6,858 (USD; Tot_Drug_Cst)2020 Drug cost: $16,883 (USD; Tot_Drug_Cst)2021 Drug cost: $22,109 (USD; Tot_Drug_Cst)2022 Drug cost: $16,611 (USD; Tot_Drug_Cst)2023 Drug cost: $18,424 (USD; Tot_Drug_Cst)2024 Drug cost: $504,085 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181527$605
201952185$6,858
202031188$16,883
202123153$22,109
202241113$16,611
20231868$18,424
202459273$504,085

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more2033$137
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1818$92
80053Blood test, comprehensive group of blood chemicals2557$10
36415Insertion of needle into vein for collection of blood sample2682$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count2680$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VenclextaVenetoclax12342$43,445
DexamethasoneDexamethasone20336$519
AcyclovirAcyclovir381,245$453
HydroxyureaHydroxyurea16655$265
PrednisonePrednisone34702$184

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$364GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sonya Joy Inderbitzin-Fischer, MD?

Tedicare shows public-source Medicare data for Sonya Joy Inderbitzin-Fischer, MD (NPI 1184128670), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sonya Joy Inderbitzin-Fischer, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sonya Joy Inderbitzin-Fischer, MD?

Sonya Joy Inderbitzin-Fischer, MD is linked to CANCER & HEMATOLOGY CENTERS OF WESTERN MI, P.C. (billing NPI 1528018389) in the available physician profile data.

Does Sonya Joy Inderbitzin-Fischer, MD have Open Payments data?

Sonya Joy Inderbitzin-Fischer, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.